"Reduction of tumor burden and increased cancer cell death was observed in all patients and removed all trace of the disease in one patient following just one week of treatment, showing its potential effectiveness," says Pandha. "Notably, no significant side effects were observed in any patient."
Imagine what would be happening with the share price if we were still listed and this kind of news was going global...
https://newatlas.com/common-cold-virus-bladder-cancer-immunotherapy-human-trial/60460/?utm_source=New+Atlas+Subscribers&utm_campaign=890da82d15-UA-2235360-4&utm_medium=email&utm_term=0_65b67362bd-890da82d15-89760586
BOD completely screwed up!!!!
Add to My Watchlist
What is My Watchlist?